Staar Surgical Co. (NASDAQ: STAA) has seen a rise in its stock price by 0.43 in relation to its previous close of 30.19. However, the company has experienced a -2.00% decline in its stock price over the last five trading sessions. businesswire.com reported 2024-10-23 that LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it will release financial results for the third quarter ended September 27, 2024, on Wednesday, October 30, 2024, after the market close. Event: STAAR Surgical 3Q 2024 Financial Results Webcast Date: Wednesday, October 30, 2024 Time: 4:30 p.m. ET / 1:30.
Is It Worth Investing in Staar Surgical Co. (NASDAQ: STAA) Right Now?
Staar Surgical Co. (NASDAQ: STAA) has a higher price-to-earnings ratio of 90.51x compared to its average ratio. STAA has 36-month beta value of 0.59. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for STAA is 48.86M, and currently, short sellers hold a 10.35% ratio of that float. The average trading volume of STAA on October 25, 2024 was 813.81K shares.
STAA’s Market Performance
STAA stock saw a decrease of -2.00% in the past week, with a monthly decline of -2.32% and a quarterly a decrease of -24.33%. The volatility ratio for the week is 3.23%, and the volatility levels for the last 30 days are 4.53% for Staar Surgical Co. (STAA). The simple moving average for the past 20 days is -7.56% for STAA’s stock, with a -19.47% simple moving average for the past 200 days.
Analysts’ Opinion of STAA
Many brokerage firms have already submitted their reports for STAA stocks, with Morgan Stanley repeating the rating for STAA by listing it as a “Underweight.” The predicted price for STAA in the upcoming period, according to Morgan Stanley is $37 based on the research report published on July 15, 2024 of the current year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see STAA reach a price target of $46. The rating they have provided for STAA stocks is “Buy” according to the report published on June 11th, 2024.
Stifel gave a rating of “Buy” to STAA, setting the target price at $50 in the report published on March 11th of the current year.
STAA Trading at -7.19% from the 50-Day Moving Average
After a stumble in the market that brought STAA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.44% of loss for the given period.
Volatility was left at 4.53%, however, over the last 30 days, the volatility rate increased by 3.23%, as shares sank -10.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.62% lower at present.
During the last 5 trading sessions, STAA fell by -2.00%, which changed the moving average for the period of 200-days by -10.82% in comparison to the 20-day moving average, which settled at $32.80. In addition, Staar Surgical Co. saw -2.85% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STAA starting from Butcher Arthur C, who purchase 1,315 shares at the price of $37.99 back on Aug 12 ’24. After this action, Butcher Arthur C now owns 4,208 shares of Staar Surgical Co., valued at $49,957 using the latest closing price.
BROADWOOD PARTNERS, L.P., the 10% Owner of Staar Surgical Co., purchase 1 shares at $42.56 during a trade that took place back on May 09 ’24, which means that BROADWOOD PARTNERS, L.P. is holding 10,768,431 shares at $43 based on the most recent closing price.
Stock Fundamentals for STAA
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.79 for the gross margin
The net margin for Staar Surgical Co. stands at 0.05. The total capital return value is set at 0.06. Equity return is now at value 4.36, with 3.49 for asset returns.
Based on Staar Surgical Co. (STAA), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 1.03. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -14.44.
Currently, EBITDA for the company is 33.22 million with net debt to EBITDA at -4.72. When we switch over and look at the enterprise to sales, we see a ratio of 4.01. The receivables turnover for the company is 3.48for trailing twelve months and the total asset turnover is 0.65. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.80.
Conclusion
To put it simply, Staar Surgical Co. (STAA) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
